These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16956368)

  • 1. A family of killer toxins. Exploring the mechanism of ADP-ribosylating toxins.
    Holbourn KP; Shone CC; Acharya KR
    FEBS J; 2006 Oct; 273(20):4579-93. PubMed ID: 16956368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis.
    Han S; Arvai AS; Clancy SB; Tainer JA
    J Mol Biol; 2001 Jan; 305(1):95-107. PubMed ID: 11114250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved structural motif for recognizing nicotinamide adenine dinucleotide in poly(ADP-ribose) polymerases and ADP-ribosylating toxins: implications for structure-based drug design.
    Lee YM; Babu CS; Chen YC; Milcic M; Qu Y; Lim C
    J Med Chem; 2010 May; 53(10):4038-49. PubMed ID: 20420408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel components of NAD-utilizing metabolic pathways and prediction of their biochemical functions.
    de Souza RF; Aravind L
    Mol Biosyst; 2012 Jun; 8(6):1661-77. PubMed ID: 22399070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ARTT motif and a unified structural understanding of substrate recognition in ADP-ribosylating bacterial toxins and eukaryotic ADP-ribosyltransferases.
    Han S; Tainer JA
    Int J Med Microbiol; 2002 Feb; 291(6-7):523-9. PubMed ID: 11890553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The best defense is a good offense--Salmonella deploys an ADP-ribosylating toxin.
    Lesnick ML; Guiney DG
    Trends Microbiol; 2001 Jan; 9(1):2-4; discussion 4-5. PubMed ID: 11166220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution and mechanism from structures of an ADP-ribosylating toxin and NAD complex.
    Han S; Craig JA; Putnam CD; Carozzi NB; Tainer JA
    Nat Struct Biol; 1999 Oct; 6(10):932-6. PubMed ID: 10504727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exchange of glutamine-217 to glutamate of Clostridium limosum exoenzyme C3 turns the asparagine-specific ADP-ribosyltransferase into an arginine-modifying enzyme.
    Vogelsgesang M; Aktories K
    Biochemistry; 2006 Jan; 45(3):1017-25. PubMed ID: 16411778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate binding and catalysis of ecto-ADP-ribosyltransferase 2.2 from rat.
    Ritter H; Koch-Nolte F; Marquez VE; Schulz GE
    Biochemistry; 2003 Sep; 42(34):10155-62. PubMed ID: 12939142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho-modifying C3-like ADP-ribosyltransferases.
    Aktories K; Wilde C; Vogelsgesang M
    Rev Physiol Biochem Pharmacol; 2004; 152():1-22. PubMed ID: 15372308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The uptake machinery of clostridial actin ADP-ribosylating toxins--a cell delivery system for fusion proteins and polypeptide drugs.
    Barth H; Blöcker D; Aktories K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):501-12. PubMed ID: 12444490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the Clostridium limosum C3 exoenzyme.
    Vogelsgesang M; Stieglitz B; Herrmann C; Pautsch A; Aktories K
    FEBS Lett; 2008 Apr; 582(7):1032-6. PubMed ID: 18325337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the RNA 2'-phosphotransferase from Aeropyrum pernix K1.
    Kato-Murayama M; Bessho Y; Shirouzu M; Yokoyama S
    J Mol Biol; 2005 Apr; 348(2):295-305. PubMed ID: 15811369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization.
    Wilde C; Vogelsgesang M; Aktories K
    Biochemistry; 2003 Aug; 42(32):9694-702. PubMed ID: 12911311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico identification of novel bacterial ADP-ribosyltransferases.
    Masignani V; Balducci E; Serruto D; Veggi D; Aricò B; Comanducci M; Pizza M; Rappuoli R
    Int J Med Microbiol; 2004 Apr; 293(7-8):471-8. PubMed ID: 15149020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology modeling and molecular dynamics studies of a novel C3-like ADP-ribosyltransferase.
    Xiao JF; Li ZS; Sun CC
    Bioorg Med Chem; 2004 May; 12(9):2035-41. PubMed ID: 15080907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous relatives of ADP-ribosylating bacterial toxins in mice and men: potential regulators of immune cell function.
    Haag F; Koch-Nolte F
    J Biol Regul Homeost Agents; 1998; 12(3):53-62. PubMed ID: 9795832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.
    Domenighini M; Magagnoli C; Pizza M; Rappuoli R
    Mol Microbiol; 1994 Oct; 14(1):41-50. PubMed ID: 7830559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of ADP-Ribosylating Bacterial Toxins.
    Chen C; Barbieri JT
    Methods Mol Biol; 2018; 1813():287-295. PubMed ID: 30097876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.